Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Operating profit has grown by an annual rate 27.06% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Jun 24
3
With ROE of 23.16%, it has a Very Expensive valuation with a 7.53 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.4%
0%
0.4%
6 Months
11.34%
0%
11.34%
1 Year
36.46%
0%
36.46%
2 Years
32.63%
0%
32.63%
3 Years
48.82%
0%
48.82%
4 Years
15.24%
0%
15.24%
5 Years
77.88%
0%
77.88%
Medacta Group SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.90%
EBIT Growth (5y)
27.06%
EBIT to Interest (avg)
6.05
Debt to EBITDA (avg)
1.01
Net Debt to Equity (avg)
0.46
Sales to Capital Employed (avg)
1.04
Tax Ratio
16.94%
Dividend Payout Ratio
19.79%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.61%
ROE (avg)
20.96%
Valuation key factors
Factor
Value
P/E Ratio
33
Industry P/E
Price to Book Value
7.53
EV to EBIT
30.25
EV to EBITDA
18.57
EV to Capital Employed
5.57
EV to Sales
5.19
PEG Ratio
0.52
Dividend Yield
NA
ROCE (Latest)
18.40%
ROE (Latest)
23.16%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
496.20
438.80
13.08%
Operating Profit (PBDIT) excl Other Income
130.60
120.50
8.38%
Interest
6.60
3.70
78.38%
Exceptional Items
-1.80
-5.50
67.27%
Consolidate Net Profit
46.00
46.40
-0.86%
Operating Profit Margin (Excl OI)
150.40%
158.10%
-0.77%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 13.08% vs 11.82% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -0.86% vs -16.70% in Dec 2022
About Medacta Group SA 
Medacta Group SA
Pharmaceuticals & Biotechnology
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.






